Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001185185-23-001027
Filing Date
2023-10-04
Accepted
2023-10-03 19:27:29
Documents
8
Effectiveness Date
2023-10-04

Document Format Files

Seq Description Document Type Size
1 FORM S-8 igcpharma20230929_s8.htm S-8 226016
2 EXHIBIT 5.1 ex_576373.htm EX-5.1 4832
3 EXHIBIT 10.2 ex_575425.htm EX-10.2 39784
4 EXHIBIT 23.1 ex_575426.htm EX-23.1 3792
5 EXHIBIT FILING FEES ex_575427.htm EX-FILING FEES 14006
6 ex_575426img001.jpg GRAPHIC 10091
7 igcpharma20230929_s8img001.jpg GRAPHIC 3093
8 igcpharma20230929_s8img002.jpg GRAPHIC 3093
  Complete submission text file 0001185185-23-001027.txt   312342
Mailing Address 10224 FALLS ROAD POTOMAC MD 20854
Business Address 10224 FALLS ROAD POTOMAC MD 20854 301-983-0998
IGC Pharma, Inc. (Filer) CIK: 0001326205 (see all company filings)

EIN.: 202760393 | State of Incorp.: MD | Fiscal Year End: 0331
Type: S-8 | Act: 33 | File No.: 333-274853 | Film No.: 231306129
SIC: 2834 Pharmaceutical Preparations